14 results on '"van de Pol V"'
Search Results
2. LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway
- Author
-
van de Pol, V., primary, Vos, M., additional, DeRuiter, M.C., additional, Goumans, M.J., additional, de Vries, C.J.M., additional, and Kurakula, K., additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
3. Endothelial colony forming cells as an autologous model to study endothelial dysfunction in patients with a bicuspid aortic valve
- Author
-
van de Pol, V. (Vera), Bons, L.R. (Lidia), Lodder, K., Kurakula, K.B. (Konda Babu), Sanchez-Duffhues, G. (Gonzalo), Siebelink, H.M.J., Roos-Hesselink, J.W. (Jolien), DeRuiter, M.C. (Marco), Goumans, M.-J. (Marie-José), van de Pol, V. (Vera), Bons, L.R. (Lidia), Lodder, K., Kurakula, K.B. (Konda Babu), Sanchez-Duffhues, G. (Gonzalo), Siebelink, H.M.J., Roos-Hesselink, J.W. (Jolien), DeRuiter, M.C. (Marco), and Goumans, M.-J. (Marie-José) more...
- Abstract
Bicuspid aortic valve (BAV), the most common congenital heart defect, is associated with an increased prevalence of aortic dilation, aortic rupture and aortic valve calcification. Endothelial cells (ECs) play a major role in vessel wall integrity. Little is known regarding EC function in BAV patients due to lack of patient derived more...
- Published
- 2019
- Full Text
- View/download PDF
4. Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve
- Author
-
van de Pol, V, Bons, Lidia, Lodder, K, Kurakula, KB, Sanchez-Duffhues, G, Siebelink, HMJ, Roos - Hesselink, Jolien, DeRuiter, MC, Goumans, MJ, van de Pol, V, Bons, Lidia, Lodder, K, Kurakula, KB, Sanchez-Duffhues, G, Siebelink, HMJ, Roos - Hesselink, Jolien, DeRuiter, MC, and Goumans, MJ more...
- Published
- 2019
5. P548Four-and-a-half LIM-domain 2 secretion is increased in the dilated aorta of bicuspid aortic valve patients
- Author
-
Van De Pol, V, primary, Kurakula, K B, additional, Bons, L R, additional, Roos-Hesselink, J W, additional, Deruiter, M C, additional, and Goumans, M J, additional
- Published
- 2018
- Full Text
- View/download PDF
6. Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function
- Author
-
Birket, M.J. (Matthew J.), Ribeiro, M.C. (Marcelo C.), Kosmidis, G. (Georgios), Ward, D. (Dorien), Leitoguinho, A.R. (Ana Rita), van de Pol, V. (Vera), Dambrot, C. (Cheryl), Devalla, H.D. (Harsha D.), Davis, R.P. (Richard P.), Mastroberardino, P.G. (Pier), Atsma, D.E. (Douwe), Passier, R. (Robert), Mummery, C.L. (Christine), Birket, M.J. (Matthew J.), Ribeiro, M.C. (Marcelo C.), Kosmidis, G. (Georgios), Ward, D. (Dorien), Leitoguinho, A.R. (Ana Rita), van de Pol, V. (Vera), Dambrot, C. (Cheryl), Devalla, H.D. (Harsha D.), Davis, R.P. (Richard P.), Mastroberardino, P.G. (Pier), Atsma, D.E. (Douwe), Passier, R. (Robert), and Mummery, C.L. (Christine) more...
- Abstract
Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is essential for their effective application in models of cardiac toxicity and disease. Here, we aimed to identify factors that would promote an adequate level of function to permit robust single-cell contractility measurements in a human induced pluripotent stem cell (hiPSC) model of hypertrophic cardiomyopathy (HCM). A simple screen revealed the collaborative effects of thyroid hormone, IGF-1 and the glucocorticoid analog dexamethasone on the electrophysiology, bioenergetics, and contractile force generation of hPSC-CMs. In this optimized condition, hiPSC-CMs with mutations in MYBPC3, a gene encoding myosin-binding protein C, which, when mutated, causes HCM, showed significantly lower contractile force generation than controls. This was recapitulated by direct knockdown of MYBPC3 in control hPSC-CMs, supporting a mechanism of haploinsufficiency. Modeling this disease in vitro using human cells is an important step toward identifying therapeutic interventions for HCM. more...
- Published
- 2015
- Full Text
- View/download PDF
7. Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function
- Author
-
Birket, MJ, Ribeiro, MC, Kosmidis, G, Ward, D, Leitoguinho, AR, van de Pol, V, Dambrot, C, Devalla, HD, Davis, RP, Mastroberardino, Pier, Atsma, DE, Passier, R, Mummery, CL, Birket, MJ, Ribeiro, MC, Kosmidis, G, Ward, D, Leitoguinho, AR, van de Pol, V, Dambrot, C, Devalla, HD, Davis, RP, Mastroberardino, Pier, Atsma, DE, Passier, R, and Mummery, CL more...
- Abstract
Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is essential for their effective application in models of cardiac toxicity and disease. Here, we aimed to identify factors that would promote an adequate level of function to permit robust single-cell contractility measurements in a human induced pluripotent stem cell (hiPSC) model of hypertrophic cardiomyopathy (HCM). A simple screen revealed the collaborative effects of thyroid hormone, IGF-1 and the glucocorticoid analog dexamethasone on the electrophysiology, bioenergetics, and contractile force generation of hPSC-CMs. In this optimized condition, hiPSC-CMs with mutations in MYBPC3, a gene encoding myosin-binding protein C, which, when mutated, causes HCM, showed significantly lower contractile force generation than controls. This was recapitulated by direct knockdown of MYBPC3 in control hPSC-CMs, supporting a mechanism of haploinsufficiency. Modeling this disease in vitro using human cells is an important step toward identifying therapeutic interventions for HCM. more...
- Published
- 2015
8. New calcification model for intact murine aortic valves.
- Author
-
Kruithof BPT, van de Pol V, Los T, Lodder K, Mousavi Gourabi B, DeRuiter MC, Goumans MJ, and Ajmone Marsan N
- Subjects
- Animals, Aortic Valve metabolism, Aortic Valve Stenosis pathology, Biomarkers, Calcification, Physiologic drug effects, Calcinosis pathology, Cell Culture Techniques, Cell Differentiation drug effects, Cell Differentiation genetics, Cells, Cultured, Dexamethasone pharmacology, Endothelial Cells metabolism, Humans, Mice, Osteogenesis drug effects, Osteogenesis genetics, Tissue Culture Techniques, Aortic Valve pathology, Aortic Valve Stenosis etiology, Aortic Valve Stenosis metabolism, Calcinosis etiology, Calcinosis metabolism, Disease Susceptibility
- Abstract
Calcific aortic valve disease (CAVD) is a common progressive disease of the aortic valves, for which no medical treatment exists and surgery represents currently the only therapeutic solution. The development of novel pharmacological treatments for CAVD has been hampered by the lack of suitable test-systems, which require the preservation of the complex valve structure in a mechanically and biochemical controllable system. Therefore, we aimed at establishing a model which allows the study of calcification in intact mouse aortic valves by using the Miniature Tissue Culture System (MTCS), an ex vivo flow model for whole mouse hearts. Aortic valves of wild-type mice were cultured in the MTCS and exposed to osteogenic medium (OSM, containing ascorbic acid, β-glycerophosphate and dexamethasone) or inorganic phosphates (PI). Osteogenic calcification occurred in the aortic valve leaflets that were cultured ex vivo in the presence of PI, but not of OSM. In vitro cultured mouse and human valvular interstitial cells calcified in both OSM and PI conditions, revealing in vitro-ex vivo differences. Furthermore, endochondral differentiation occurred in the aortic root of ex vivo cultured mouse hearts near the hinge of the aortic valve in both PI and OSM conditions. Dexamethasone was found to induce endochondral differentiation in the aortic root, but to inhibit calcification and the expression of osteogenic markers in the aortic leaflet, partly explaining the absence of calcification in the aortic valve cultured with OSM. The osteogenic calcifications in the aortic leaflet and the endochondral differentiation in the aortic root resemble calcifications found in human CAVD. In conclusion, we have established an ex vivo calcification model for intact wild-type murine aortic valves in which the initiation and progression of aortic valve calcification can be studied. The in vitro-ex vivo differences found in our studies underline the importance of ex vivo models to facilitate pre-clinical translational studies., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.) more...
- Published
- 2021
- Full Text
- View/download PDF
9. Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve.
- Author
-
van de Pol V, Bons LR, Lodder K, Kurakula KB, Sanchez-Duffhues G, Siebelink HJ, Roos-Hesselink JW, DeRuiter MC, and Goumans MJ
- Subjects
- Adult, Aorta pathology, Aortic Valve pathology, Bicuspid Aortic Valve Disease, Cell Movement, Cell Size, Cells, Cultured, Dilatation, Pathologic pathology, Female, Humans, Male, Middle Aged, Young Adult, Aortic Valve abnormalities, Endothelial Cells pathology, Heart Valve Diseases pathology
- Abstract
Bicuspid aortic valve (BAV), the most common congenital heart defect, is associated with an increased prevalence of aortic dilation, aortic rupture and aortic valve calcification. Endothelial cells (ECs) play a major role in vessel wall integrity. Little is known regarding EC function in BAV patients due to lack of patient derived primary ECs. Endothelial colony forming cells (ECFCs) have been reported to be a valid surrogate model for several cardiovascular pathologies, thereby facilitating an in vitro system to assess patient-specific endothelial dysfunction. Therefore, the aim of this study was to investigate cellular functions in ECFCs isolated from BAV patients. Outgrowth and proliferation of ECFCs from patients with BAV ( n = 34) and controls with a tricuspid aortic valve (TAV, n = 10) were determined and related to patient characteristics. Interestingly, we were only able to generate ECFCs from TAV and BAV patients without aortic dilation, and failed to isolate ECFC colonies from patients with a dilated aorta. Analyzing EC function showed that while proliferation, cell size and endothelial-to-mesenchymal transition were similar in TAV and BAV ECFCs, migration and the wound healing capacity of BAV ECFCs is significantly higher compared to TAV ECFCs. Furthermore, calcification is blunted in BAV compared to TAV ECFCs. Our results reveal ECs dysfunction in BAV patients and future research is required to unravel the underlying mechanisms and to further validate ECFCs as a patient-specific in vitro model for BAV. more...
- Published
- 2019
- Full Text
- View/download PDF
10. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2.
- Author
-
Sánchez-Duffhues G, García de Vinuesa A, van de Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H, Lindeman JH, Goumans MJ, and Ten Dijke P
- Subjects
- Animals, Cell Differentiation drug effects, Cells, Cultured, Down-Regulation drug effects, Down-Regulation physiology, Endothelial Cells physiology, Endothelium, Vascular pathology, Epithelial-Mesenchymal Transition drug effects, Humans, Inflammation Mediators pharmacology, Interleukin-1beta pharmacology, Mice, Inbred C3H, Osteogenesis drug effects, Osteogenesis physiology, Signal Transduction physiology, Tumor Necrosis Factor-alpha pharmacology, Vascular Calcification pathology, Bone Morphogenetic Protein Receptors, Type II physiology, Epithelial-Mesenchymal Transition physiology, Vascular Calcification physiopathology
- Abstract
Endothelial-to-mesenchymal transition (EndMT) has been unveiled as a common cause for a multitude of human pathologies, including cancer and cardiovascular disease. Vascular calcification is a risk factor for ischemic vascular disorders and slowing calcification may reduce mortality in affected patients. The absence of early biomarkers hampers the identification of patients at risk. EndMT and vascular calcification are induced upon cooperation between distinct stimuli, including inflammatory cytokines and transforming growth factor beta (TGF-β) family members. However, how these signaling pathways interplay to promote cell differentiation and eventually vascular calcification is not well understood. Using in vitro and ex vivo analysis in animal models and patient-derived tissues, we have identified that the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) induce EndMT in human primary aortic endothelial cells, thereby sensitizing them for BMP-9-induced osteogenic differentiation. Downregulation of the BMP type II receptor BMPR2 is a key event in this process. Rather than compromising BMP canonical signal transduction, loss of BMPR2 results in decreased JNK signaling in ECs, thus enhancing BMP-9-induced mineralization. Altogether, our results point at the BMPR2-JNK signaling axis as a key pathway regulating inflammation-induced EndMT and contributing to calcification. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland., (© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.) more...
- Published
- 2019
- Full Text
- View/download PDF
11. Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?
- Author
-
van de Pol V, Kurakula K, DeRuiter MC, and Goumans MJ
- Abstract
Bicuspid aortic valve (BAV) is the most common type of congenital cardiac malformation. Patients with a BAV have a predisposition for the development of thoracic aortic aneurysm (TAA). This pathological aortic dilation may result in aortic rupture, which is fatal in most cases. The abnormal aortic morphology of TAAs results from a complex series of events that alter the cellular structure and extracellular matrix (ECM) composition of the aortic wall. Because the major degeneration is located in the media of the aorta, most studies aim to unravel impaired smooth muscle cell (SMC) function in BAV TAA. However, recent studies suggest that endothelial cells play a key role in both the initiation and progression of TAAs by influencing the medial layer. Aortic endothelial cells are activated in BAV mediated TAAs and have a substantial influence on ECM composition and SMC phenotype, by secreting several key growth factors and matrix modulating enzymes. In recent years there have been significant advances in the genetic and molecular understanding of endothelial cells in BAV associated TAAs. In this review, the involvement of the endothelial cells in BAV TAA pathogenesis is discussed. Endothelial cell functioning in vessel homeostasis, flow response and signaling will be highlighted to give an overview of the importance and the under investigated potential of endothelial cells in BAV-associated TAA. more...
- Published
- 2017
- Full Text
- View/download PDF
12. Comparative Analysis of the Equivital EQ02 Lifemonitor with Holter Ambulatory ECG Device for Continuous Measurement of ECG, Heart Rate, and Heart Rate Variability: A Validation Study for Precision and Accuracy.
- Author
-
Akintola AA, van de Pol V, Bimmel D, Maan AC, and van Heemst D
- Abstract
Background: The Equivital (EQ02) is a multi-parameter telemetric device offering both real-time and/or retrospective, synchronized monitoring of ECG, HR, and HRV, respiration, activity, and temperature. Unlike the Holter, which is the gold standard for continuous ECG measurement, EQO2 continuously monitors ECG via electrodes interwoven in the textile of a wearable belt. Objective: To compare EQ02 with the Holter for continuous home measurement of ECG, heart rate (HR), and heart rate variability (HRV). Methods: Eighteen healthy participants wore, simultaneously for 24 h, the Holter and EQ02 monitors. Per participant, averaged HR, and HRV per 5 min from the two devices were compared using Pearson correlation, paired T -test, and Bland-Altman analyses. Accuracy and precision metrics included mean absolute relative difference (MARD). Results: Artifact content of EQ02 data varied widely between (range 1.93-56.45%) and within (range 0.75-9.61%) participants. Comparing the EQ02 to the Holter, the Pearson correlations were respectively 0.724, 0.955, and 0.997 for datasets containing all data and data with < 50 or < 20% artifacts respectively. For datasets containing respectively all data, data with < 50, or < 20% artifacts, bias estimated by Bland-Altman analysis was -2.8, -1.0, and -0.8 beats per minute and 24 h MARD was 7.08, 3.01, and 1.5. After selecting a 3-h stretch of data containing 1.15% artifacts, Pearson correlation was 0.786 for HRV measured as standard deviation of NN intervals (SDNN). Conclusions: Although the EQ02 can accurately measure ECG and HRV, its accuracy and precision is highly dependent on artifact content. This is a limitation for clinical use in individual patients. However, the advantages of the EQ02 (ability to simultaneously monitor several physiologic parameters) may outweigh its disadvantages (higher artifact load) for research purposes and/ or for home monitoring in larger groups of study participants. Further studies can be aimed at minimizing the artifacts. more...
- Published
- 2016
- Full Text
- View/download PDF
13. Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function.
- Author
-
Birket MJ, Ribeiro MC, Kosmidis G, Ward D, Leitoguinho AR, van de Pol V, Dambrot C, Devalla HD, Davis RP, Mastroberardino PG, Atsma DE, Passier R, and Mummery CL
- Subjects
- Animals, Cardiomyopathy, Hypertrophic, Cell Differentiation, Cell Line, Electrophysiology, Flow Cytometry, Humans, Mice, Mutation genetics, Carrier Proteins genetics, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Pluripotent Stem Cells cytology, Pluripotent Stem Cells metabolism
- Abstract
Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is essential for their effective application in models of cardiac toxicity and disease. Here, we aimed to identify factors that would promote an adequate level of function to permit robust single-cell contractility measurements in a human induced pluripotent stem cell (hiPSC) model of hypertrophic cardiomyopathy (HCM). A simple screen revealed the collaborative effects of thyroid hormone, IGF-1 and the glucocorticoid analog dexamethasone on the electrophysiology, bioenergetics, and contractile force generation of hPSC-CMs. In this optimized condition, hiPSC-CMs with mutations in MYBPC3, a gene encoding myosin-binding protein C, which, when mutated, causes HCM, showed significantly lower contractile force generation than controls. This was recapitulated by direct knockdown of MYBPC3 in control hPSC-CMs, supporting a mechanism of haploinsufficiency. Modeling this disease in vitro using human cells is an important step toward identifying therapeutic interventions for HCM., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2015
- Full Text
- View/download PDF
14. Inhibition of the central melanocortin system decreases brown adipose tissue activity.
- Author
-
Kooijman S, Boon MR, Parlevliet ET, Geerling JJ, van de Pol V, Romijn JA, Havekes LM, Meurs I, and Rensen PC
- Subjects
- Animals, Apolipoprotein E3 genetics, Apolipoprotein E3 metabolism, Female, Mice, Mice, Transgenic, Oxidation-Reduction drug effects, Receptor, Melanocortin, Type 3 genetics, Receptor, Melanocortin, Type 3 metabolism, Receptor, Melanocortin, Type 4 genetics, Receptor, Melanocortin, Type 4 metabolism, Adipose Tissue, Brown metabolism, Melanocyte-Stimulating Hormones pharmacology, Receptor, Melanocortin, Type 3 antagonists & inhibitors, Receptor, Melanocortin, Type 4 antagonists & inhibitors, Signal Transduction drug effects
- Abstract
The melanocortin system is an important regulator of energy balance, and melanocortin 4 receptor (MC4R) deficiency is the most common monogenic cause of obesity. We investigated whether the relationship between melanocortin system activity and energy expenditure (EE) is mediated by brown adipose tissue (BAT) activity. Therefore, female APOE*3-Leiden.CETP transgenic mice were fed a Western-type diet for 4 weeks and infused intracerebroventricularly with the melanocortin 3/4 receptor (MC3/4R) antagonist SHU9119 or vehicle for 2 weeks. SHU9119 increased food intake (+30%) and body fat (+50%) and decreased EE by reduction in fat oxidation (-42%). In addition, SHU9119 impaired the uptake of VLDL-TG by BAT. In line with this, SHU9119 decreased uncoupling protein-1 levels in BAT (-60%) and induced large intracellular lipid droplets, indicative of severely disturbed BAT activity. Finally, SHU9119-treated mice pair-fed to the vehicle-treated group still exhibited these effects, indicating that MC4R inhibition impairs BAT activity independent of food intake. These effects were not specific to the APOE*3-Leiden.CETP background as SHU9119 also inhibited BAT activity in wild-type mice. We conclude that inhibition of central MC3/4R signaling impairs BAT function, which is accompanied by reduced EE, thereby promoting adiposity. We anticipate that activation of MC4R is a promising strategy to combat obesity by increasing BAT activity., (Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.) more...
- Published
- 2014
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.